• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXO1在抑制前列腺癌细胞中雄激素受体非雄激素依赖性激活方面的转录非依赖性功能。

A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.

作者信息

Liu Ping, Li Shangwei, Gan Lu, Kao Timothy P, Huang Haojie

机构信息

Department of Laboratory Medicine and Pathology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, USA.

出版信息

Cancer Res. 2008 Dec 15;68(24):10290-9. doi: 10.1158/0008-5472.CAN-08-2038.

DOI:10.1158/0008-5472.CAN-08-2038
PMID:19074897
Abstract

Increasing evidence suggests that aberrant activation of the androgen receptor (AR) plays a pivotal role in the development and progression of androgen depletion-independent prostate cancer (PCa) after androgen deprivation therapy. Here, we show that loss of the PTEN tumor suppressor gene is associated with hyperactivation of the AR in human PCa cell lines. This effect is mediated primarily by its downstream effector FOXO1. In addition to the inhibition of androgenic activation of the AR, forced expression of FOXO1 in PTEN-negative PCa cells also inhibits androgen-independent activation of the AR in a manner independent of FOXO1 transcriptional function. In contrast, silencing of FOXO1 in PTEN-positive cells not only increases the basal activity of the AR in the absence of androgens, it also markedly sensitizes the AR activation by low levels of androgens or nonandrogenic factors such as interleukin-6. FOXO1-mediated inhibition of the AR is partially attenuated by the histone deacetylase (HDAC) inhibitor trichostatin A. Accordingly, FOXO1 interacts with HDAC3 as shown by coimmunoprecipitation assays, and cotransfection of cells with FOXO1 and HDAC3, but not HDAC1 and HDAC2, results in a greater inhibition of AR activity than in cells transfected with FOXO1 or HDAC3 individually. Together, our findings define a novel corepressor function of FOXO1 in inhibition of androgen-independent activation of the AR.

摘要

越来越多的证据表明,雄激素受体(AR)的异常激活在雄激素剥夺治疗后雄激素非依赖性前列腺癌(PCa)的发生和发展中起关键作用。在此,我们表明PTEN肿瘤抑制基因的缺失与人类PCa细胞系中AR的过度激活相关。这种效应主要由其下游效应因子FOXO1介导。除了抑制AR的雄激素激活外,在PTEN阴性的PCa细胞中强制表达FOXO1还以独立于FOXO1转录功能的方式抑制AR的雄激素非依赖性激活。相反,在PTEN阳性细胞中沉默FOXO1不仅会增加在无雄激素情况下AR的基础活性,还会显著增强低水平雄激素或白细胞介素-6等非雄激素因子对AR的激活作用。组蛋白去乙酰化酶(HDAC)抑制剂曲古抑菌素A可部分减弱FOXO1介导的对AR的抑制作用。因此,共免疫沉淀试验表明FOXO1与HDAC3相互作用,并且与单独转染FOXO1或HDAC3的细胞相比,将FOXO1和HDAC3共转染到细胞中对AR活性的抑制作用更强,而HDAC1和HDAC2则无此作用。总之,我们的研究结果确定了FOXO1在抑制AR雄激素非依赖性激活中的一种新的共抑制因子功能。

相似文献

1
A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.FOXO1在抑制前列腺癌细胞中雄激素受体非雄激素依赖性激活方面的转录非依赖性功能。
Cancer Res. 2008 Dec 15;68(24):10290-9. doi: 10.1158/0008-5472.CAN-08-2038.
2
Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.抑制雄激素受体作为紫杉醇治疗前列腺癌的新机制。
Cancer Res. 2009 Nov 1;69(21):8386-94. doi: 10.1158/0008-5472.CAN-09-1504. Epub 2009 Oct 13.
3
FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.FOXO1 与 TAU5 基序结合,抑制组成型激活的雄激素受体剪接变体。
Prostate. 2013 Jul;73(10):1017-27. doi: 10.1002/pros.22649. Epub 2013 Feb 6.
4
Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.胰岛素样生长因子1/胰岛素信号通过Foxo1与雄激素受体的直接相互作用激活雄激素信号。
J Biol Chem. 2007 Mar 9;282(10):7329-38. doi: 10.1074/jbc.M610447200. Epub 2007 Jan 2.
5
Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.FOXA1和FOXO1因子对前列腺癌中雄激素受体的调节作用
Int J Biol Sci. 2014 Jun 5;10(6):614-9. doi: 10.7150/ijbs.8389. eCollection 2014.
6
FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.FOXP1是一种雄激素反应性转录因子,它在前列腺癌细胞中负向调节雄激素受体信号传导。
Biochem Biophys Res Commun. 2008 Sep 19;374(2):388-93. doi: 10.1016/j.bbrc.2008.07.056. Epub 2008 Jul 18.
7
FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment.FoxO1介导PTEN对雄激素受体N端和C端相互作用以及共激活因子募集的抑制作用。
Mol Endocrinol. 2009 Feb;23(2):213-25. doi: 10.1210/me.2008-0147. Epub 2008 Dec 12.
8
Androgen-dependent regulation of Her-2/neu in prostate cancer cells.雄激素对前列腺癌细胞中Her-2/neu的依赖性调控。
Cancer Res. 2006 Jun 1;66(11):5723-8. doi: 10.1158/0008-5472.CAN-05-3928.
9
Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.抑制HER-2/neu激酶会损害雄激素受体募集至雄激素反应增强子。
Cancer Res. 2005 Apr 15;65(8):3404-9. doi: 10.1158/0008-5472.CAN-04-4292.
10
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.分化剂丁酸盐在人前列腺癌细胞中对雄激素受体的非配体依赖性激活。
Cancer Res. 2000 Oct 15;60(20):5825-31.

引用本文的文献

1
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond.组蛋白去乙酰化酶驱动的抗癌耐药机制:表观遗传学及其他。
Cancer Drug Resist. 2024 Nov 20;7:46. doi: 10.20517/cdr.2024.103. eCollection 2024.
2
Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor.癌症和免疫疗法疗效的性别差异:雄激素受体的作用。
Front Immunol. 2024 May 28;15:1416941. doi: 10.3389/fimmu.2024.1416941. eCollection 2024.
3
FoxO1 Controls Redox Regulation and Cellular Physiology of BV-2 Microglial Cells.FoxO1调控BV-2小胶质细胞的氧化还原调节和细胞生理学。
Inflammation. 2023 Apr;46(2):752-762. doi: 10.1007/s10753-022-01771-5. Epub 2022 Dec 14.
4
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms.前列腺癌对第二代抗雄激素的耐药性:途径与机制
Cancer Drug Resist. 2020 Sep 17;3(4):742-761. doi: 10.20517/cdr.2020.45. eCollection 2020.
5
Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer.前列腺癌中细胞因子存在时对雄激素及雄激素受体拮抗剂的反应
Cancers (Basel). 2021 Jun 12;13(12):2944. doi: 10.3390/cancers13122944.
6
Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL.Hdac3 通过抑制破骨细胞对 RANKL 的反应来调节骨建模。
J Biol Chem. 2020 Dec 18;295(51):17713-17723. doi: 10.1074/jbc.RA120.013573.
7
Knockout of Akt1/2 suppresses the metastasis of human prostate cancer cells CWR22rv1 in vitro and in vivo.敲除 Akt1/2 抑制人前列腺癌细胞 CWR22rv1 的体内外转移。
J Cell Mol Med. 2021 Feb;25(3):1546-1553. doi: 10.1111/jcmm.16246. Epub 2020 Dec 29.
8
The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?雄激素对 T 细胞的影响:女性在自身免疫性肝病中占优势的线索?
Front Immunol. 2020 Jul 29;11:1567. doi: 10.3389/fimmu.2020.01567. eCollection 2020.
9
Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer.雄激素受体激动剂和拮抗剂介导前列腺癌细胞衰老的机制
Cancers (Basel). 2020 Jul 8;12(7):1833. doi: 10.3390/cancers12071833.
10
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.PI3K-AKT-mTOR 通路与前列腺癌:AR、MAPK 和 WNT 信号的十字路口。
Int J Mol Sci. 2020 Jun 25;21(12):4507. doi: 10.3390/ijms21124507.